-
Je něco špatně v tomto záznamu ?
Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data
O. Oikonomou, S. Sarrou, CC. Papagiannitsis, S. Georgiadou, K. Mantzarlis, E. Zakynthinos, GN. Dalekos, E. Petinaki,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
BioMedCentral
od 2001-12-01
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-02-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-01-01
Health & Medicine (ProQuest)
od 2009-01-01
Public Health Database (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
- MeSH
- Acinetobacter baumannii účinky léků izolace a purifikace MeSH
- antibakteriální látky farmakologie MeSH
- infekce bakteriemi rodu Acinetobacter epidemiologie mikrobiologie MeSH
- karbapenemy farmakologie MeSH
- kolistin farmakologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- mnohočetná bakteriální léková rezistence účinky léků MeSH
- molekulární typizace MeSH
- nemocnice MeSH
- pulzní gelová elektroforéza MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Řecko MeSH
BACKGROUND: Colistin-resistant/carbapenem-resistant Acinetobacter baumannii is a significant challenge for antibiotic treatment and infection control policies. Since 2012, in Central Greece an increase of colistin/pan- resistant A. baumannii has occurred, indicating the need for further analysis. METHODS: A total of 86 colistin-resistant/carbapenem-resistant out of 1228 A. baumannii clinical isolates, consecutively collected between 2012 and 2014 in a tertiary Greek hospital of Central Greece, as well as one environmental isolate from surveillance cultures were studied. Molecular typing and mechanisms of resistance to colistin and to carbapenems were assessed, whereas, epidemiological and clinical data of the patients were reviewed. RESULTS: During the study period, the rate of colistin resistance gradually increased and reached 21.1 % in 2014. All colistin-resistant/carbapenem-resistant A. baumannii belonged to 3LST ST101 clone that corresponds to the international clonal lineage II. Carbapenem resistance was associated with the presence of bla oxa-23-like, while resistance to colistin probably correlated with G54E and R109H amino acid substitutions in PmrA and PmrC, respectively. CONCLUSIONS: Epidemiological data of the patients indicated that the first detection of colistin-resistant/carbapenem-resistant ST101 clone in the University Hospital of Larissa (UHL) was associated with a patient who previously had received colistin, while, the movement of the infected patients into the hospital probably resulted to its spread.
Department of Critical Care Medical School University of Thessaly Larissa Greece
Department of Medicine Medical School University of Thessaly Larissa Greece
Department of Microbiology University Hospital of Larissa Larissa Greece
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16027853
- 003
- CZ-PrNML
- 005
- 20161021101303.0
- 007
- ta
- 008
- 161005s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12879-015-1297-x $2 doi
- 024 7_
- $a 10.1186/s12879-015-1297-x $2 doi
- 035 __
- $a (PubMed)26653099
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Oikonomou, O $u Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
- 245 10
- $a Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data / $c O. Oikonomou, S. Sarrou, CC. Papagiannitsis, S. Georgiadou, K. Mantzarlis, E. Zakynthinos, GN. Dalekos, E. Petinaki,
- 520 9_
- $a BACKGROUND: Colistin-resistant/carbapenem-resistant Acinetobacter baumannii is a significant challenge for antibiotic treatment and infection control policies. Since 2012, in Central Greece an increase of colistin/pan- resistant A. baumannii has occurred, indicating the need for further analysis. METHODS: A total of 86 colistin-resistant/carbapenem-resistant out of 1228 A. baumannii clinical isolates, consecutively collected between 2012 and 2014 in a tertiary Greek hospital of Central Greece, as well as one environmental isolate from surveillance cultures were studied. Molecular typing and mechanisms of resistance to colistin and to carbapenems were assessed, whereas, epidemiological and clinical data of the patients were reviewed. RESULTS: During the study period, the rate of colistin resistance gradually increased and reached 21.1 % in 2014. All colistin-resistant/carbapenem-resistant A. baumannii belonged to 3LST ST101 clone that corresponds to the international clonal lineage II. Carbapenem resistance was associated with the presence of bla oxa-23-like, while resistance to colistin probably correlated with G54E and R109H amino acid substitutions in PmrA and PmrC, respectively. CONCLUSIONS: Epidemiological data of the patients indicated that the first detection of colistin-resistant/carbapenem-resistant ST101 clone in the University Hospital of Larissa (UHL) was associated with a patient who previously had received colistin, while, the movement of the infected patients into the hospital probably resulted to its spread.
- 650 _2
- $a infekce bakteriemi rodu Acinetobacter $x epidemiologie $x mikrobiologie $7 D000151
- 650 _2
- $a Acinetobacter baumannii $x účinky léků $x izolace a purifikace $7 D040981
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a karbapenemy $x farmakologie $7 D015780
- 650 _2
- $a kolistin $x farmakologie $7 D003091
- 650 _2
- $a mnohočetná bakteriální léková rezistence $x účinky léků $7 D024901
- 650 _2
- $a pulzní gelová elektroforéza $7 D016521
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a nemocnice $7 D006761
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a molekulární typizace $7 D058889
- 651 _2
- $a Řecko $x epidemiologie $7 D006115
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sarrou, S $u Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
- 700 1_
- $a Papagiannitsis, C C $u Department of Microbiology, University Hospital of Larissa, Larissa, Greece. Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic.
- 700 1_
- $a Georgiadou, S $u Department of Medicine, Medical School, University of Thessaly, Larissa, Greece.
- 700 1_
- $a Mantzarlis, K $u Department of Critical Care, Medical School, University of Thessaly, Larissa, Greece.
- 700 1_
- $a Zakynthinos, E $u Department of Critical Care, Medical School, University of Thessaly, Larissa, Greece.
- 700 1_
- $a Dalekos, G N $u Department of Medicine, Medical School, University of Thessaly, Larissa, Greece.
- 700 1_
- $a Petinaki, E $u Department of Microbiology, University Hospital of Larissa, Larissa, Greece. petinaki@med.uth.gr. Department of Microbiology, Medical School, University of Thessaly, Larissa, Greece. petinaki@med.uth.gr.
- 773 0_
- $w MED00008185 $t BMC infectious diseases $x 1471-2334 $g Roč. 15, č. - (2015), s. 559
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26653099 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20161021101712 $b ABA008
- 999 __
- $a ok $b bmc $g 1166167 $s 952483
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 15 $c - $d 559 $e 20151209 $i 1471-2334 $m BMC infectious diseases $n BMC Infect Dis $x MED00008185
- LZP __
- $a Pubmed-20161005